(RxWiki News) Lung transplant recipients can experience a number of side effects after surgery such as the inability to feel the urge to cough when they need to expel lung secretions.
Another side effect is called bronchiolitis obliterates syndrome (BOS), which occurs when excess scar tissue clogs air pathways in the lungs, thus cutting off the patient's ability to breathe.
BOS, which has no cure, is the primary cause of death of lung transplant recipients after one year. However, a recent study may have identified a new method for diagnosing the syndrome early enough to intervene and save patients' lives.
Researchers from the University of Michigan have discovered a relationship between the number of stem cells in recipients' lungs and the risk of developing BOS. Vibha Lama, M.D., M.S., assistant professor of pulmonary and critical care medicine at the University of Michigan Medical School, and colleagues analyzed lung fluid samples from 162 transplant recipients. They found that, six months after operation, those with a higher stem cell count in their lungs had a greater risk of developing BOS than those exhibiting lower counts.
According to Vibha, current methods of BOS detection can diagnose the syndrome only after the lungs have been significantly damaged. As such, this finding has the potential to reduce the number of deaths caused by BOS.